Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis.

Yawen JiangJia LiuXin ChenWenying YangWeiping JiaJing Wu

Published in: Advances in therapy (2021)

Regimens of GLP-1RAs had differential glycemic control and cardiometabolic effectiveness. Policymaking and patient-centric clinical decisions should take into consideration the comparative effectiveness profiles.

Keyphrases

glycemic control
type diabetes
blood glucose
randomized controlled trial
systematic review
case report
weight loss
insulin resistance
adipose tissue
skeletal muscle